SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-030100
Filing Date
2020-05-18
Accepted
2020-05-18 16:34:02
Documents
1
Period of Report
2020-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2347
  Complete submission text file 0001209191-20-030100.txt   3835
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT PKWY SOUTH SAN FRANCISCO CA 94080
Business Address
Lieu Hsiao D (Reporting) CIK: 0001468482 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38853 | Film No.: 20890058